The effect of information about the benefits and harms of mammography on women's decision-making

The decision to participate or not in breast cancer screening is complex due to the trade-off between the expected benefit of breast cancer mortality reduction and the major harm of overdiagnosis. It seems ethically necessary to inform women so that they can actively participate in decision-making a...

Descripción completa

Detalles Bibliográficos
Autores: Carles-Lavila, Misericòrdia|||0000-0003-3796-3014, Martinez-Alonso, Montserrat|||0000-0003-1504-8552, Pons, Anna, Pérez-Lacasta, María José|||0000-0001-5906-5632, Perestelo-Pérez, Lilisbeth|||0000-0002-6113-7313, Sala, Maria|||0000-0002-9955-8746, Vidal, Carmen|||0000-0003-2768-2710, García, Montserrat|||0000-0002-3437-3185, Toledo-Chávarri, Ana, Codern-Bové, Núria|||0000-0003-0210-7488, Feijoo Cid, Maria|||0000-0002-7010-373X, Romero, Anabel, Pla, Roger, Soler-González, Jorge, Castells, Xavier|||0000-0002-2528-0382, Rué, Montserrat|||0000-0002-7862-9365
Tipo de recurso: artículo
Fecha de publicación:2017
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:253981
Acceso en línea:https://ddd.uab.cat/record/253981
https://dx.doi.org/urn:doi:10.1186/s13063-017-2161-7
Access Level:acceso abierto
Palabra clave:Screening
Breast cancer
Informed choice
Early detection
Decision aids
Descripción
Sumario:The decision to participate or not in breast cancer screening is complex due to the trade-off between the expected benefit of breast cancer mortality reduction and the major harm of overdiagnosis. It seems ethically necessary to inform women so that they can actively participate in decision-making and make an informed choice based on their values and preferences. The objective of this study is to assess the effects of receiving information about the benefits and harms of screening on decision-making, in women approaching the age of invitation to mammography screening. A two-stage, randomized controlled trial (RCT). In the first stage, 40 Basic Health Areas (BHAs) will be selected and randomized to intervention or control. In the second stage, women within each BHA will be randomly selected (n = 400). Four breast cancer screening programs (BCSPs) of the Spanish public health system, three in Catalonia and one in the Canary Islands will participate in the study. Women in the intervention arm will receive a leaflet with detailed information on the benefits and harms of screening using mammography. Women in the control arm will receive a standard leaflet that does not mention harms and recommends accepting the invitation to participate in the biennial examinations of the BCSP. The primary outcome is informed choice, a dichotomous variable that combines knowledge, attitudes, and intentions. Secondary outcomes include decisional conflict; confidence in the decision made; anxiety about screening participation; worry about breast cancer; anticipated regret; time perspective; perceived importance of benefits/harms of screening; perceived risk of breast cancer; and leaflet acceptability. Primary and secondary outcomes are assessed 2-3 weeks after the intervention. This is the first RCT that assesses the effect of informing about the benefits and harms of breast cancer screening in Spain in women facing the decision to be screened using mammography. It aims to assess the impact of information on several decisional outcomes and to contribute to paving the road towards shared decision-making in breast cancer screening in our country.